Real-World Outcomes of Ribociclib in HR+/HER2– Metastatic Breast Cancer: A Single-Center Retrospective Study from Southern Taiwan

First Author / 第一作者

Shih-Yu Huang

Institution / 單位

Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan

Audio / 音訊檔

Author Group / 作者群

Shih-Yu Huang 1 M.D., Shih-Chung Wu 2 M.D., Ching-Hua Tsai 2 M.D., Ming Chun Kuo 1 , M.D., Chien-Ting Liu 1*, M.D. *Corresponding author

Author Group Institution/ 作者群單位

1. Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan. 2. Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Breast cancer, metastatic, ribociclib, real-world

Back to list